Profound Medical Corp
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada. Show More...
-
Website https://www.profoundmedical.com
-
Sector Healthcare
-
Industry Medical Devices
-
Last Quote 7.21 CAD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CAD -6.9 -3.9 -3.1 -2.07 -1.82 -1.8 Dividends CAD Payout Ratio % * Shares Mil 2.0 4.0 6.0 10.0 11.0 12.0 Book Value Per Share * CAD 4.22 0.53 2.51 2.88 1.97 4.67 Free Cash Flow Per Share * CAD -4.53 -3.12 -2.84 -2.02 -1.72 Return on Assets % -143.04 -72.75 -72.99 -55.79 -47.18 -32.73 Financial Leverage (Average) 1.52 1.59 1.97 1.75 2.09 1.1 Return on Equity % -210.6 -113.38 -129.91 -101.86 -89.17 -42.14 Return on Invested Capital % -81.63 -76.71 -87.96 -70.38 -54.66 -34.36 Interest Coverage -2.04 -18.71 -12.91 -18.96 -13.6 -11.16 Current Ratio 16.52 4.54 1.64 4.81 2.77 16.41 Quick Ratio 16.41 4.32 1.45 4.3 2.2 14.88 Debt/Equity 0.4 0.25 0.03 0.4 0.47 0.03